European regulatory aspects on new medicines targeted at treatment of rheumatoid arthritis.
Kreutz
G
G
Bundesinstitut für Arzreimittel und Medizinprodukte, Seestrabetae 10, 13353 Berlin, Germany.
D018501:Antirheumatic Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D018849:Controlled Clinical Trials as Topic / Q000379:methods; D017277:Drug Approval / Q000331:legislation & jurisprudence / Q000458:organization & administration*; D005062:European Union; D006801:Humans; D016896:Treatment Outcome
D018501:Antirheumatic Agents